Analyst Ratings For athenahealth (NASDAQ:ATHN)
Today, Piper Jaffray Companies reiterated its Buy rating on athenahealth (NASDAQ:ATHN) with a price target of $160.00.
Some recent analyst ratings include
- 2/16/2018-Piper Jaffray Companies Reiterated Rating of Buy.
- 1/18/2018-Evercore ISI initiated coverage with a In rating.
- 1/12/2018-KeyCorp Reiterated Rating of Buy.
- 1/4/2018-Citigroup initiated coverage with a Neutral rating.
- On 2/5/2018 Jonathan Bush, CEO, sold 25,000 with an average share price of $145.00 per share and the total transaction amounting to $3,625,000.00.
- On 2/2/2018 Brandon H Hull, Director, sold 653 with an average share price of $133.00 per share and the total transaction amounting to $86,849.00.
- On 2/1/2018 Jonathan Bush, CEO, sold 5,000 with an average share price of $122.69 per share and the total transaction amounting to $613,450.00.
- On 1/26/2018 Jonathan D. Porter, SVP, sold 150 with an average share price of $128.26 per share and the total transaction amounting to $19,239.00.
- On 1/2/2018 David Eric Robinson, Director, sold 5,000 with an average share price of $133.94 per share and the total transaction amounting to $669,700.00.
- On 12/29/2017 Jonathan D Porter, SVP, sold 150 with an average share price of $134.52 per share and the total transaction amounting to $20,178.00.
- On 12/29/2017 Jonathan D. Porter, SVP, sold 150 with an average share price of $134.52 per share and the total transaction amounting to $20,178.00.
Recent Trading Activity for athenahealth (NASDAQ:ATHN)
Shares of athenahealth closed the previous trading session at 139.45 down -1.79 1.27% with shares trading hands.